IMMUNOMODULATION BY ENZYME IL4I1

IL4I1 is an immunosuppressive enzyme highly expressed in all cancers by infiltrating macrophages and in some cases, such as B lymphomas and mesotheliomas, by tumor cells. Its expression in the tumor bed favors immune escape. This process might result in a defective response to immunotherapy in cancers, in particular in the cases, which have failed or become resistant to anti-checkpoint treatments. We propose specific inhibitors of enzyme IL4I1 to enhance the anti-tumor immune response.

Applications

• All types of cancers presenting a macrophage infiltrate
• Melanoma
• Lymphoma
• Mesothelioma

Competitive advantages

• Efficient inhibitors of IL4I1
• Non toxic

Intellectual property

• Patent application filed on March 2018

Keywords

Cancer - Anti-tumor - Immunomodulation - Immunosuppressive enzyme - IL4I1 - Immunotherapy